The effect of the GLP-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes:a randomized double-blind placebo-controlled cross over study

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Heart failure LV dysfunction Ventricular function / haemodynamics ESC Premium Access ESC Congress 2016

ESC 365 is supported by

ESC 365 is supported by